Hinge Health, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Hinge Health, Inc. | HNGE - NYSE |
TBD |
$0.00 |
$0.00 | TBD | |
Morgan Stanley, Barclays, BofA Securities, Evercore ISI, RBC Capital, Truist Securities, Stifel, William Blair, Piper Sandler, Canaccord Genuity, KeyBanc Capital, Needham & Co., Raymond James, KKR |
Co-Manager(s): |
Health Care |
Filing(s): Filed 2025-03-10
|
For IPO Boutique's "scale of 1 to 5" BUY rating on Hinge Health, Inc., and our comprehensive analysis, click "Buy Market Research".
About Hinge Health, Inc. (adapted from Hinge Health, Inc. prospectus):
Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "HNGE" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2025 IPO Boutique. All Rights Reserved